Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes. | N Engl J Med;387(16): 1529-1530, 2022 10 20. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes.

Senoo, Yuki; Kami, Masahiro.

Affiliation

Senoo Y; Medical Governance Research Institute, Tokyo, Japan senooyuki0821@gmail.com.
Kami M; Medical Governance Research Institute, Tokyo, Japan senooyuki0821@gmail.com.

N Engl J Med ; 387(16): 1529-1530, 2022 10 20.

Article in En | MEDLINE | ID: mdl-36260804

Subject(s)

Diabetes Mellitus, Type 2; Adolescent; Humans; Diabetes Mellitus, Type 2/drug therapy; Glucagon-Like Peptides/adverse effects; Immunoglobulin Fc Fragments/adverse effects; Recombinant Fusion Proteins/adverse effects

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Limits: Adolescent / Humans Language: En Journal: N Engl J Med Year: 2022 Document type: Article Affiliation country: Japan

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Limits: Adolescent / Humans Language: En Journal: N Engl J Med Year: 2022 Document type: Article Affiliation country: Japan